Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
Trials have studied retatrutide in adults with obesity (BMI 30) or overweight (BMI 27) with comorbidities
The first is if youre experiencing any persistent abdominal pain (especially if it radiates to your back), vomiting that persists for longer than a day, or signs of dehydration like dizziness or markedly reduced urination
Retatrutide takes this foundation and builds upon it with GIP receptor activation (which enhances insulin response and may reduce GLP-1 related nausea) plus glucagon receptor activation (which increases energy expenditure and fat breakdown)
DOI: 10.1038/s41387-025-00386-7
In line with the covalent binding mechanism, in vitro and cell-based thermal-shift assays showed that C1-27 induced a negative shift in the melting temperature indicating protein destabilization on binding (Supplementary Figs 11 and 15)
US$ 24.04
US$ 24.30
US$ 22.26
US$ 29.73
US$ 21.69
